SCHEMBL31665550

SCHEMBL31665550

Cc1ccc(NC(=O)c2ccccc2NC(=O)CCCCNC(=O)OC(C)(C)C)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.49
▸ SAE1 Q9UBE0 1/20 0.48
▸ UBA2 Q9UBT2 1/20 0.48
▸ RAB9A P51151 3/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ KDM4E B2RXH2 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ TP53 P04637 1/20 0.47
▸ GLA P06280 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ CYP3A4 P08684 1/20 0.46
▸ F10 P00742 1/20 0.45
▸ HDAC3 O15379 6/20 0.44
▸ HDAC1 Q13547 5/20 0.44
▸ HTT P42858 1/20 0.44
▸ MAPK1 P28482 1/20 0.43
▸ HDAC2 Q92769 1/20 0.43
▸ HDAC8 Q9BY41 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31665459 0.89 NPC1 (0.48) KMT2ASAE1UBA2RAB9ANPC1
SCHEMBL31665489 0.83 SAE1 (0.46) KMT2ASAE1UBA2RAB9ANPC1
SCHEMBL31110239 0.81 SAE1 (0.53) KMT2ASAE1UBA2RAB9ANPC1
SCHEMBL25142396 0.81 NPC1 (0.55) KMT2ASAE1UBA2RAB9ANPC1
SCHEMBL25142573 0.81 NPC1 (0.58) KMT2ASAE1UBA2RAB9ANPC1
SCHEMBL31110128 0.81 NPC1 (0.55) KMT2ASAE1UBA2RAB9ANPC1
SCHEMBL31110238 0.81 NPC1 (0.58) KMT2ASAE1UBA2RAB9ANPC1
SCHEMBL25143602 0.78 NPC1 (0.47) KMT2ARAB9ANPC1SMN1; SMN2TP53
SCHEMBL25143693 0.78 NPC1 (0.43) KMT2ARAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL31665588 0.78 NPC1 (0.43) KMT2ARAB9ANPC1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250235543-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2025-07-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250235543-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, TP53BP1 KMT2A 2300/4885SAE1 114/4885UBA2 127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback